Jonušaitė, I. et al. 2024. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab. Neurologijos seminarai. 27, Nr. 3 (97) (Mar. 2024), 127–135. DOI:https://doi.org/10.29014/NS.2023.27.97.1.